Katrina Abuabara, MD

Dermatologist

Clinics

Dermatology Clinic
1701 Divisadero St., Third and Fourth Floors
San Francisco, CA 94115
Phone: (415) 353–7800
Fax: (415) 353–7870

Hours: Monday to Friday, 8 a.m. – 5 p.m.

Board Certification

Dermatology, American Board of Dermatology

Academic Title

Assistant Professor

More about Katrina Abuabara

Education

Harvard School of Medicine 2010

Residencies

Hospital of the University of Pennsylvania 2014

Selected Research and Publications

  1. Abuabara K, Asgari MM, Chen SC, Dellavalle RP, Kalia S, Secrest AM, Silverberg JI, Solomon JA, Weinstock MA, Wu JJ, Chren MM. How data can deliver for dermatology. J Am Acad Dermatol. 2018 Mar 21.
  2. Abuabara K, Flohr C. Is new better than tried and tested? Topical atopic dermatitis treatment in context. Br J Dermatol. 2018 Mar; 178(3):583-584.
  3. Naik HB, Abuabara K. Systematic reviews of case reports and case series: from anecdote to evidence. Br J Dermatol. 2018 Feb; 178(2):317-318.
  4. Ban L, Langan SM, Abuabara K, Thomas KS, Abdul Sultan A, Sach T, McManus E, Santer M, Ratib S. Incidence and sociodemographic characteristics of eczema diagnosis in children: A†cohort study. J Allergy Clin Immunol. 2018 Jan 31.
  5. Dizon MP, Yu AM, Singh RK, Wan J, Chren MM, Flohr C, Silverberg J, Margolis DJ, Langan SM, Abuabara K. Systematic review of atopic dermatitis disease definition in studies using routinely-collected health data. Br J Dermatol. 2018 Jan 16.
  6. Abuabara K, Yu AM, Okhovat JP, Allen IE, Langan SM. The prevalence of atopic dermatitis beyond childhood: A systematic review and meta-analysis of longitudinal studies. Allergy. 2018 Mar; 73(3):696-704.
  7. von Kobyletzki LB, Beckman L, Smeeth L, McKee M, Quint JK, Abuabara K, Langan S. Association between childhood allergic diseases, educational attainment and occupational status in later life: systematic review protocol. BMJ Open. 2017 Oct 11; 7(10):e017245.
  8. Flohr C, Abuabara K, Bath-Hextall F, Nast A, van Zuuren E. Introducing the new Evidence-Based Dermatology section. Br J Dermatol. 2017 10; 177(4):885-887.
  9. Ascott A, Yu AM, Schmidt M, Abuabara K, Smeeth L, Langan SM. Association between eczema and major cardiovascular outcomes in population-based studies: a systematic review protocol. BMJ Open. 2017 Sep 29; 7(9):e017979.
  10. von Kobyletzki LB, Beckman L, Smirnova J, Smeeth L, Williams HC, McKee M, Abuabara K, Langan SM. Eczema and educational attainment: a systematic review. Br J Dermatol. 2017 09; 177(3):e47-e49.
  11. Abuabara K, Hoffstad O, Troxel AB, Gelfand JM, McCulloch CE, Margolis DJ. Patterns and predictors of atopic dermatitis disease control past childhood: An observational cohort study. J Allergy Clin Immunol. 2018 Feb; 141(2):778-780.e6.
  12. Abuabara K, Langan SM, Yu AM. Conclusions about atopic dermatitis persistence might be premature. J Am Acad Dermatol. 2017 05; 76(5):e177-e178.
  13. Abuabara K, Margolis DJ, Langan SM. The Long-Term Course of Atopic Dermatitis. Dermatol Clin. 2017 Jul; 35(3):291-297.
  14. Langan SM, Abuabara K, Henrickson SE, Hoffstad O, Margolis DJ. Increased Risk of Cutaneous and Systemic†Infections in Atopic Dermatitis-A Cohort Study. J Invest Dermatol. 2017 Jun; 137(6):1375-1377.
  15. Dizon M, Linos E, Arron ST, Abuabara K, Ruiz de Luzuriaga AM, Jin C, Boscardin WJ, Chren MM. Comparisons of patients' satisfaction should take expectations into account. Br J Dermatol. 2017 Jan; 176(1):252-254.
  16. Barbarot S, Rogers NK, Abuabara K, Aubert H, Chalmers J, Flohr C, Hanifin J, Naldi L, Margolis DJ, Paul C, Ridd MJ, Schuttelaar MA, Simpson E, Tauber M, Volke A, Weidinger S, Wilkes SR, Wollenberg A, Thomas KS. Strategies used for measuring long-term control in atopic dermatitis trials: A systematic review. J Am Acad Dermatol. 2016 11; 75(5):1038-1044.
  17. Chalmers JR, Simpson E, Apfelbacher CJ, Thomas KS, von Kobyletzki L, Schmitt J, Singh JA, Svensson Ň, Williams HC, Abuabara K, Aoki V, Ardeleanu M, Awici-Rasmussen M, Barbarot S, Berents TL, Block J, Bragg A, Burton T, Bjerring Clemmensen KK, Creswell-Melville A, Dinesen M, Drucker A, Eckert L, Flohr C, Garg M, Gerbens LA, Graff AL, Hanifin J, Heinl D, Humphreys R, Ishii HA, Kataoka Y, Leshem YA, Marquort B, Massuel MA, Merhand S, Mizutani H, Murota H, Murrell DF, Nakahara T, Nasr I, Nograles K, Ohya Y, Osterloh I, Pander J, Prinsen C, Purkins L, Ridd M, Sach T, Schuttelaar ML, Shindo S, Smirnova J, Sulzer A, SynnÝve Gjerde E, Takaoka R, Vestby Talmo H, Tauber M, Torchet F, Volke A, Wahlgren CF, Weidinger S, Weisshaar E, Wollenberg A, Yamaga K, Zhao CY, Spuls PI. Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative). Br J Dermatol. 2016 Jul; 175(1):69-79.
  18. Margolis DJ, Abuabara K, Hoffstad OJ, Wan J, Raimondo D, Bilker WB. Association Between Leukemia and Topical Use of Pimecrolimus-Reply. JAMA Dermatol. 2015 Dec 01; 151(12):1391-1392.
  19. Abuabara K, Margolis DJ. Databases for Clinical Research. J Invest Dermatol. 2015 Aug; 135(8):1-4.
  20. Margolis DJ, Abuabara K, Hoffstad OJ, Wan J, Raimondo D, Bilker WB. Association Between Malignancy and Topical Use of Pimecrolimus. JAMA Dermatol. 2015 Jun; 151(6):594-9.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.